CLAffinity: A Software Tool for Identification of Optimum Ligand Affinity for Competition-Based Primary Screens

Area of Science:

• Biochemistry
• Drug Discovery
• Assay Development

Background:

• Competition assays are widely used in drug discovery for screening compounds.
• A common assumption is that lower affinity labeled ligands yield more sensitive assays.
• Existing recommendations for ligand selection are often misapplied to primary screening.

Purpose of the Study:

• To investigate the impact of labeled ligand affinity on competition assay sensitivity in primary screening.
• To develop a tool for simulating competition experiments and determining optimal ligand affinities.
• To provide practical guidance for improving the performance of primary competition-based screens.

Main Methods:

• Development of the CLAffinity software tool for simulating competition experiments.
• Analysis of protein, ligand, and inhibitor concentrations typical in drug screening.
• Validation of simulation results against established principles of biochemical interactions.

Main Results:

• Using very high affinity labeled ligands in primary screens can paradoxically reduce assay sensitivity.
• Optimal labeled ligand affinity ranges are dependent on specific assay parameters, not general rules.
• The CLAffinity tool identifies appropriate ligand affinities to maximize assay sensitivity.

Conclusions:

• Misapplication of high-affinity ligand recommendations can lead to the discarding of active compounds.
• The CLAffinity tool and associated lookup tables enable optimization of primary competition assays.
• Implementing these tools will enhance the identification of valuable hit compounds, especially for challenging targets.